Sun Pharma hits 52- week high on USFDA all-clear to Ankleshwar unit

Sun Pharma hits 52- week high on USFDA all-clear to Ankleshwar unit
Sun Pharma hits 52- week high on USFDA all-clear to Ankleshwar unit The USFDA classified the unit as No Action Indicated, paving the way for manufacturing and export from the plant, a CNBC Awaaz report said

admin